The Assessment of Doctor’s and Nurses’ knowledge, Attitudes, and Clinical Practice in Managing the Risk of Adverse Drug Reactions (ADR)

Abstract

Objective: This study aims to explore aspects of pharmacovigilance and adverse drug reaction (ADR) reporting, including knowledge, attitudes, practice, and perceived barriers from a nurse perspective. Methodology: A systematic review was conducted by searching electronic databases such as MEDLINE, Embase Scopus and Web of Knowledge between January 2010 to October 2020. Original observational studies focusing on Nurses’ and Doctor’s understanding about pharmacovigilance activities in different healthcare settings were included if they written in English language. Results: From the search process carried out during this period we identified twenty-three qualifying studies that met our inclusion criteria. Findings revealed that while as many as 74.1% of nurses had an awareness regarding definitions related to ADRs only one quarter knew how to fill up an adverse drug reaction reporting form accurately. Further analysis showed most (84%) believe it is important for patient/medicine safety but reportage remained low at just over one-fifth because lack education/training barrier which stood around median percentage value amounting close-to half among all surveyed respondents emerged repeatedly across multiple variables studied here - appropriateness expanding such education interventions through enhancing degree-level courses ought help address these obstacles hampering routine involvement with adequate standardisation measures required ensuring better compliance rates overall especially amongst nursing cohorts globally." Conclusion: Despite favorable attitude towards ADER, there exist considerable gaps within obtained results owing various factors contributing them; thus developing requisite skillsets along training programs extending beyond basic clinical guidelines could be beneficial strategies supporting vigilante scientist endeavours geared achieving improved tracking communicate feedback loop susceptible populations exposed drugs monitored systematically enabling timely response prevent cause lasting harm overall health infrastructure systems alike taken cognizant imperative stakeholder interests involved ultimately yielding positive gains everyone aerospace .